XU Bin, DONG Pei-ling, LI Ruo-yu, WANG Ai-ping, YU Jin, WAN Zhe. Clinical Features and CD4+/CD8+ T Lymphocytes in HIV/AIDS Patients with Oropharyngeal Candidiasis[J].Chinese Journal of Dermatology, 2004, 37(5): 256-258.
[1] Darouiche RO. Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues. Clin Infect Dis, 1998,26: 259-272. [2] Campo J, Del Romero J, Castilla J, et al. Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients. J Oral Pathol Med, 2002, 31:5-10. [3] Greenspan D, Komaroff E, Redford M, et al. Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS). J Acquir Immune Defic Syndr, 2000, 25:44-50. [4] Robinson PG, Challacombe SJ, Sheiham A, et al. Is erythematous candidiasis associated with advanced HIV disease? Oral Dis, 1997,3 Suppl 1:S116-S118. [5] Ceballos-Salobrena A, Aguirre-Urizar JM, Bagan-Sebastian JV. Oral manifestations associated with human immunodeficiency virus infection in a Spanish population. J Oral Pathol Med, 1996, 25:523-526. [6] MacPhail LA, Komaroff E, Alves ME, et al. Differences in risk factors among clinical types of oral candidiasis in the Women's Interagency HIV Study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2002, 93:45-55.